Lifestyle factors and visceral adipose tissue: Results from the PREDIMED-PLUS study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 04 10 2018
accepted: 28 12 2018
entrez: 26 1 2019
pubmed: 27 1 2019
medline: 24 10 2019
Statut: epublish

Résumé

Visceral adipose tissue (VAT) is a strong predictor of cardiometabolic health, and lifestyle factors may have a positive influence on VAT depot. This study aimed to assess the cross-sectional associations between baseline levels of physical activity (PA), sedentary behaviours (SB) and adherence to the Mediterranean diet (MedDiet) with VAT depot in older individuals with overweight/obesity and metabolic syndrome. Baseline data of the PREDIMED-Plus study including a sample of 1,231 Caucasian men and women aged 55-75 years were used. Levels of leisure-time PA (total, light, and moderate-to-vigorous, in METs·min/day) and SB (total and TV-viewing, in h/day) were evaluated using validated questionnaires. Adherence to the MedDiet was evaluated using a 17-item energy-restricted MedDiet (erMedDiet) screener. The chair-stand test was used to estimate the muscle strength. VAT depot was assessed with DXA-CoreScan. Multivariable adjusted linear regression models were used to evaluate the association between lifestyle factors and VAT. For the statistics we had used multiadjusted linear regression models. Total leisure-time PA (100 METs·min/day: β -24.3g, -36.7;-11.9g), moderate-to-vigorous PA (β -27.8g, 95% CI -40.8;-14.8g), chair-stand test (repeat: β -11.5g, 95% CI -20.1;-2.93g) were inversely associated, and total SB (h/day: β 38.2g, 95% CI 14.7;61.7) positively associated with VAT. Light PA, TV-viewing time and adherence to an erMedDiet were not significantly associated with VAT. In older adults with overweigh/obesity and metabolic syndrome, greater PA, muscle strength, and lower total SB were associated with less VAT depot. In this study, adherence to an erMedDiet was not associated with lower VAT.

Sections du résumé

BACKGROUND
Visceral adipose tissue (VAT) is a strong predictor of cardiometabolic health, and lifestyle factors may have a positive influence on VAT depot. This study aimed to assess the cross-sectional associations between baseline levels of physical activity (PA), sedentary behaviours (SB) and adherence to the Mediterranean diet (MedDiet) with VAT depot in older individuals with overweight/obesity and metabolic syndrome.
METHODS
Baseline data of the PREDIMED-Plus study including a sample of 1,231 Caucasian men and women aged 55-75 years were used. Levels of leisure-time PA (total, light, and moderate-to-vigorous, in METs·min/day) and SB (total and TV-viewing, in h/day) were evaluated using validated questionnaires. Adherence to the MedDiet was evaluated using a 17-item energy-restricted MedDiet (erMedDiet) screener. The chair-stand test was used to estimate the muscle strength. VAT depot was assessed with DXA-CoreScan. Multivariable adjusted linear regression models were used to evaluate the association between lifestyle factors and VAT. For the statistics we had used multiadjusted linear regression models.
RESULTS
Total leisure-time PA (100 METs·min/day: β -24.3g, -36.7;-11.9g), moderate-to-vigorous PA (β -27.8g, 95% CI -40.8;-14.8g), chair-stand test (repeat: β -11.5g, 95% CI -20.1;-2.93g) were inversely associated, and total SB (h/day: β 38.2g, 95% CI 14.7;61.7) positively associated with VAT. Light PA, TV-viewing time and adherence to an erMedDiet were not significantly associated with VAT.
CONCLUSIONS
In older adults with overweigh/obesity and metabolic syndrome, greater PA, muscle strength, and lower total SB were associated with less VAT depot. In this study, adherence to an erMedDiet was not associated with lower VAT.

Identifiants

pubmed: 30682078
doi: 10.1371/journal.pone.0210726
pii: PONE-D-18-28856
pmc: PMC6347417
doi:

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0210726

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Br J Nutr. 2010 Jun;103(12):1808-16
pubmed: 20102675
Obes Res. 2002 Oct;10(10):1065-73
pubmed: 12376588
Clin Nutr. 2015 Dec;34(6):1266-72
pubmed: 26499033
Int J Obes (Lond). 2011 Mar;35(3):427-35
pubmed: 20820172
Crit Rev Food Sci Nutr. 2018;58(18):3070-3084
pubmed: 29039967
Med Sci Sports Exerc. 2011 May;43(5):822-8
pubmed: 20980928
PLoS One. 2013;8(1):e54225
pubmed: 23326600
Obes Rev. 2012 Jan;13(1):68-91
pubmed: 21951360
Med Sci Sports Exerc. 2016 Apr;48(4):633-40
pubmed: 26501231
Obesity (Silver Spring). 2012 Jun;20(6):1313-8
pubmed: 22282048
PLoS One. 2017 Mar 8;12(3):e0172253
pubmed: 28273154
Eur Rev Med Pharmacol Sci. 2015 May;19(10):1779-84
pubmed: 26044220
Int J Epidemiol. 2019 Apr 1;48(2):387-388o
pubmed: 30476123
PLoS One. 2017 Jan 13;12(1):e0168148
pubmed: 28085886
Med Sci Sports Exerc. 2011 Aug;43(8):1575-81
pubmed: 21681120
Int J Obes (Lond). 2007 Dec;31(12):1786-97
pubmed: 17637702
N Engl J Med. 2003 Jun 26;348(26):2599-608
pubmed: 12826634
Diabetologia. 2012 Nov;55(11):2895-905
pubmed: 22890825
J Am Coll Cardiol. 2013 Sep 3;62(10):921-5
pubmed: 23850922
Arch Intern Med. 2012 Mar 26;172(6):494-500
pubmed: 22450936
PLoS One. 2011;6(8):e23384
pubmed: 21858094
Diabetes Obes Metab. 2010 Mar;12(3):204-9
pubmed: 20151996
JAMA Oncol. 2015 Sep;1(6):766-76
pubmed: 26181634
Br J Nutr. 2014 Apr 28;111(8):1481-7
pubmed: 24382017
J Obes. 2016;2016:2719014
pubmed: 27777796
Obesity (Silver Spring). 2018 Jan;26(1):29-36
pubmed: 29265769
PLoS One. 2015 Nov 30;10(11):e0143925
pubmed: 26618489
Maturitas. 2012 Dec;73(4):337-43
pubmed: 23021800
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Res Q Exerc Sport. 1999 Jun;70(2):113-9
pubmed: 10380242
Med Sci Sports Exerc. 2017 Oct;49(10):2064-2070
pubmed: 28574874
Nutr Metab Cardiovasc Dis. 2015 Jun;25(6):569-74
pubmed: 25921850
Int J Epidemiol. 2016 Dec 1;45(6):1887-1894
pubmed: 28089956
J Nutr. 2011 Jun;141(6):1140-5
pubmed: 21508208
PLoS One. 2013;8(2):e56415
pubmed: 23409182
Med Sci Sports Exerc. 2017 Mar;49(3):450-458
pubmed: 27749387
Med Sci Sports Exerc. 2015 May;47(5):983-9
pubmed: 25207926
J Am Heart Assoc. 2015 Mar 03;4(3):e001379
pubmed: 25736442
Public Health Nutr. 2005 Oct;8(7):920-7
pubmed: 16277809
JAMA. 2018 Nov 20;320(19):2020-2028
pubmed: 30418471
Circulation. 2018 Mar 13;137(11):1143-1157
pubmed: 29142011
Clin Nutr. 2019 Aug;38(4):1883-1891
pubmed: 30031660

Auteurs

Aina M Galmes-Panades (AM)

Balearic Islands Health Research Institute (IdISBa), University Hospital Son Espases, Palma de Mallorca, Spain.
CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.

Jadwiga Konieczna (J)

Balearic Islands Health Research Institute (IdISBa), University Hospital Son Espases, Palma de Mallorca, Spain.
CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.

Itziar Abete (I)

CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.
Department of Nutrition, Food Sciences and Physiology, Center for Nutrition Research, University of Navarra (UNAV), Pamplona, Spain.

Antoni Colom (A)

Balearic Islands Health Research Institute (IdISBa), University Hospital Son Espases, Palma de Mallorca, Spain.
CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.

Núria Rosique-Esteban (N)

CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.
Human Nutrition Unit, University Hospital of Sant Joan de Reus, Department of Biochemistry and Biotechnology, Pere Virgili Institute for Health Research, Rovira i Virgili University, Reus, Spain.

Maria Angeles Zulet (MA)

CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.
Department of Nutrition, Food Sciences and Physiology, Center for Nutrition Research, University of Navarra (UNAV), Pamplona, Spain.

Zenaida Vázquez (Z)

CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain.

Ramón Estruch (R)

CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.
Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.

Josep Vidal (J)

Department of Endocrinology, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.
CIBER Diabetes and Metabolic Diseases (CIBERdem), Health Institute Carlos III (ISCIII), Madrid, Spain.

Estefanía Toledo (E)

CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain.

Nancy Babio (N)

CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.
Human Nutrition Unit, University Hospital of Sant Joan de Reus, Department of Biochemistry and Biotechnology, Pere Virgili Institute for Health Research, Rovira i Virgili University, Reus, Spain.

Miguel Fiol (M)

Balearic Islands Health Research Institute (IdISBa), University Hospital Son Espases, Palma de Mallorca, Spain.
CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.

Rosa Casas (R)

CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.
Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.

Josep Vera (J)

Institute for Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Pilar Buil-Cosiales (P)

CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain.
Primary Care, Health Service of Navarra-Osasunbidea, Pamplona, Spain.

José Antonio de Paz (JA)

Division of Preventive Medicine, University of León, León, Spain.

Albert Goday (A)

Lipids and Cardiovascular Epidemiology Research Unit, Municipal Institute of Medical Research (IMIM), Barcelona, Spain.

Jordi Salas-Salvadó (J)

CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.
Human Nutrition Unit, University Hospital of Sant Joan de Reus, Department of Biochemistry and Biotechnology, Pere Virgili Institute for Health Research, Rovira i Virgili University, Reus, Spain.

J Alfredo Martínez (JA)

CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.
Department of Nutrition, Food Sciences and Physiology, Center for Nutrition Research, University of Navarra (UNAV), Pamplona, Spain.
Madrid Institute for Advanced Studies (IMDEA) Food Institute, Madrid, Spain.

Dora Romaguera (D)

Balearic Islands Health Research Institute (IdISBa), University Hospital Son Espases, Palma de Mallorca, Spain.
CIBER Pathophysiology of Obesity and Nutrition (CIBEROBN), Health Institute Carlos III (ISCIII), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH